Yellow Phosphorus
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Therapeutic Vaccines Market Research Report 2024
1 Therapeutic Vaccines Market Overview
1.1 Product Overview and Scope of Therapeutic Vaccines
1.2 Therapeutic Vaccines Segment by Type
1.2.1 Global Therapeutic Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Peptide Therapeutic Vaccine
1.2.3 Cell Therapeutic Vaccine
1.2.4 Nucleic Acid Therapeutic Vaccine
1.3 Therapeutic Vaccines Segment by Application
1.3.1 Global Therapeutic Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Global Therapeutic Vaccines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Vaccines Revenue 2017-2028
1.4.2 Global Therapeutic Vaccines Sales 2017-2028
1.4.3 Therapeutic Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Therapeutic Vaccines Market Competition by Manufacturers
2.1 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Therapeutic Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Therapeutic Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Therapeutic Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Therapeutic Vaccines Market Competitive Situation and Trends
2.5.1 Therapeutic Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Therapeutic Vaccines Players Market Share by Revenue
2.5.3 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Vaccines Retrospective Market Scenario by Region
3.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Therapeutic Vaccines Market Facts & Figures by Country
3.3.1 North America Therapeutic Vaccines Sales by Country
3.3.2 North America Therapeutic Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Therapeutic Vaccines Market Facts & Figures by Country
3.4.1 Europe Therapeutic Vaccines Sales by Country
3.4.2 Europe Therapeutic Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Therapeutic Vaccines Sales by Region
3.5.2 Asia Pacific Therapeutic Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Therapeutic Vaccines Market Facts & Figures by Country
3.6.1 Latin America Therapeutic Vaccines Sales by Country
3.6.2 Latin America Therapeutic Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Therapeutic Vaccines Sales by Country
3.7.2 Middle East and Africa Therapeutic Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Therapeutic Vaccines Historic Market Analysis by Type
4.1 Global Therapeutic Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Therapeutic Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Therapeutic Vaccines Price by Type (2017-2022)
5 Global Therapeutic Vaccines Historic Market Analysis by Application
5.1 Global Therapeutic Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Therapeutic Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Therapeutic Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Northeast Biotherapeutics
6.1.1 Northeast Biotherapeutics Corporation Information
6.1.2 Northeast Biotherapeutics Description and Business Overview
6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
6.1.5 Northeast Biotherapeutics Recent Developments/Updates
6.2 Agenus
6.2.1 Agenus Corporation Information
6.2.2 Agenus Description and Business Overview
6.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Agenus Therapeutic Vaccines Product Portfolio
6.2.5 Agenus Recent Developments/Updates
6.3 Vaccinogen Inc
6.3.1 Vaccinogen Inc Corporation Information
6.3.2 Vaccinogen Inc Description and Business Overview
6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio
6.3.5 Vaccinogen Inc Recent Developments/Updates
6.4 CIMAB S.A
6.4.1 CIMAB S.A Corporation Information
6.4.2 CIMAB S.A Description and Business Overview
6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 CIMAB S.A Therapeutic Vaccines Product Portfolio
6.4.5 CIMAB S.A Recent Developments/Updates
6.5 Dendreon
6.5.1 Dendreon Corporation Information
6.5.2 Dendreon Description and Business Overview
6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Dendreon Therapeutic Vaccines Product Portfolio
6.5.5 Dendreon Recent Developments/Updates
6.6 Corixa
6.6.1 Corixa Corporation Information
6.6.2 Corixa Description and Business Overview
6.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Corixa Therapeutic Vaccines Product Portfolio
6.6.5 Corixa Recent Developments/Updates
6.7 AVAX Technologies
6.6.1 AVAX Technologies Corporation Information
6.6.2 AVAX Technologies Description and Business Overview
6.6.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AVAX Technologies Therapeutic Vaccines Product Portfolio
6.7.5 AVAX Technologies Recent Developments/Updates
7 Therapeutic Vaccines Manufacturing Cost Analysis
7.1 Therapeutic Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Therapeutic Vaccines
7.4 Therapeutic Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Therapeutic Vaccines Distributors List
8.3 Therapeutic Vaccines Customers
9 Therapeutic Vaccines Market Dynamics
9.1 Therapeutic Vaccines Industry Trends
9.2 Therapeutic Vaccines Market Drivers
9.3 Therapeutic Vaccines Market Challenges
9.4 Therapeutic Vaccines Market Restraints
10 Global Market Forecast
10.1 Therapeutic Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Therapeutic Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Therapeutic Vaccines by Type (2023-2028)
10.2 Therapeutic Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Therapeutic Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Therapeutic Vaccines by Application (2023-2028)
10.3 Therapeutic Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Therapeutic Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Therapeutic Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Therapeutic Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Therapeutic Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Therapeutic Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Therapeutic Vaccines Market Competitive Situation by Manufacturers in 2021
Table 5. Global Therapeutic Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Therapeutic Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Therapeutic Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Therapeutic Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Therapeutic Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Therapeutic Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Therapeutic Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Therapeutic Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Vaccines as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Therapeutic Vaccines Sales by Region (2017-2022) & (K Units)
Table 16. Global Therapeutic Vaccines Sales Market Share by Region (2017-2022)
Table 17. Global Therapeutic Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Therapeutic Vaccines Revenue Market Share by Region (2017-2022)
Table 19. North America Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)
Table 20. North America Therapeutic Vaccines Sales Market Share by Country (2017-2022)
Table 21. North America Therapeutic Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Therapeutic Vaccines Revenue Market Share by Country (2017-2022)
Table 23. Europe Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)
Table 24. Europe Therapeutic Vaccines Sales Market Share by Country (2017-2022)
Table 25. Europe Therapeutic Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Therapeutic Vaccines Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Therapeutic Vaccines Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Therapeutic Vaccines Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Therapeutic Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Therapeutic Vaccines Revenue Market Share by Region (2017-2022)
Table 31. Latin America Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Therapeutic Vaccines Sales Market Share by Country (2017-2022)
Table 33. Latin America Therapeutic Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Therapeutic Vaccines Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Therapeutic Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Global Therapeutic Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Global Therapeutic Vaccines Sales Market Share by Type (2017-2022)
Table 41. Global Therapeutic Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Therapeutic Vaccines Revenue Share by Type (2017-2022)
Table 43. Global Therapeutic Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Therapeutic Vaccines Sales (K Units) by Application (2017-2022)
Table 45. Global Therapeutic Vaccines Sales Market Share by Application (2017-2022)
Table 46. Global Therapeutic Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Therapeutic Vaccines Revenue Share by Application (2017-2022)
Table 48. Global Therapeutic Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 49. Northeast Biotherapeutics Corporation Information
Table 50. Northeast Biotherapeutics Description and Business Overview
Table 51. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Northeast Biotherapeutics Therapeutic Vaccines Product
Table 53. Northeast Biotherapeutics Recent Developments/Updates
Table 54. Agenus Corporation Information
Table 55. Agenus Description and Business Overview
Table 56. Agenus Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Agenus Therapeutic Vaccines Product
Table 58. Agenus Recent Developments/Updates
Table 59. Vaccinogen Inc Corporation Information
Table 60. Vaccinogen Inc Description and Business Overview
Table 61. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Vaccinogen Inc Therapeutic Vaccines Product
Table 63. Vaccinogen Inc Recent Developments/Updates
Table 64. CIMAB S.A Corporation Information
Table 65. CIMAB S.A Description and Business Overview
Table 66. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. CIMAB S.A Therapeutic Vaccines Product
Table 68. CIMAB S.A Recent Developments/Updates
Table 69. Dendreon Corporation Information
Table 70. Dendreon Description and Business Overview
Table 71. Dendreon Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Dendreon Therapeutic Vaccines Product
Table 73. Dendreon Recent Developments/Updates
Table 74. Corixa Corporation Information
Table 75. Corixa Description and Business Overview
Table 76. Corixa Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Corixa Therapeutic Vaccines Product
Table 78. Corixa Recent Developments/Updates
Table 79. AVAX Technologies Corporation Information
Table 80. AVAX Technologies Description and Business Overview
Table 81. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. AVAX Technologies Therapeutic Vaccines Product
Table 83. AVAX Technologies Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Therapeutic Vaccines Distributors List
Table 87. Therapeutic Vaccines Customers List
Table 88. Therapeutic Vaccines Market Trends
Table 89. Therapeutic Vaccines Market Drivers
Table 90. Therapeutic Vaccines Market Challenges
Table 91. Therapeutic Vaccines Market Restraints
Table 92. Global Therapeutic Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 93. Global Therapeutic Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Therapeutic Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Therapeutic Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Therapeutic Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 97. Global Therapeutic Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Therapeutic Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Therapeutic Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Therapeutic Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 101. Global Therapeutic Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Therapeutic Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Therapeutic Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Therapeutic Vaccines
Figure 2. Global Therapeutic Vaccines Market Share by Type in 2021 & 2028
Figure 3. Peptide Therapeutic Vaccine Product Picture
Figure 4. Cell Therapeutic Vaccine Product Picture
Figure 5. Nucleic Acid Therapeutic Vaccine Product Picture
Figure 6. Global Therapeutic Vaccines Market Share by Application in 2021 & 2028
Figure 7. Oncotherapy
Figure 8. Hepatitis B
Figure 9. Tuberculosis
Figure 10. Herpes Simplex Virus
Figure 11. Others
Figure 12. Global Therapeutic Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Therapeutic Vaccines Market Size (2017-2028) & (US$ Million)
Figure 14. Global Therapeutic Vaccines Sales (2017-2028) & (K Units)
Figure 15. Therapeutic Vaccines Sales Share by Manufacturers in 2021
Figure 16. Global Therapeutic Vaccines Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Therapeutic Vaccines Players: Market Share by Revenue in 2021
Figure 18. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Therapeutic Vaccines Sales Market Share by Region (2017-2022)
Figure 20. Global Therapeutic Vaccines Sales Market Share by Region in 2021
Figure 21. Global Therapeutic Vaccines Revenue Market Share by Region (2017-2022)
Figure 22. Global Therapeutic Vaccines Revenue Market Share by Region in 2021
Figure 23. U.S. Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. China Taiwan Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Therapeutic Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Therapeutic Vaccines by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Therapeutic Vaccines
Figure 47. Manufacturing Process Analysis of Therapeutic Vaccines
Figure 48. Therapeutic Vaccines Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Northeast Biotherapeutics Agenus Vaccinogen Inc CIMAB S.A Dendreon Corixa AVAX Technologies